Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Post by xodcodeon Oct 11, 2023 5:43pm
589 Views
Post# 35679599

TPST, a harbinger for TLT?

TPST, a harbinger for TLT?Could this happen to Theralase?

Earlier today someone posted on the day’s explosion of the TPST (Tempest Therapeutics, Inc) share price.

Tempest, like Theralase, appears to be a small biotech start-up presently with no product revenues. The company, founded in 2017, focuses on innovative (proprietary) cancer treatments by “...developing first-in-class small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity.” Another small start-up biotech with no products to sell; just some “innovative” disease treatment concepts, centered on cancer and the immune system.

https://ir.tempesttx.com/

In a news release this morning the company announced that data analysis of a “Phase 1b/2 clinical study in which TPST-1120, Tempest’s PPAR antagonist, shows clinical superiority in multiple study endpoints when combined with atezolizumab and bevacizumab in a randomized comparison to atezolizumab and bevacizumab in the first-line treatment of patients with unresectable or metastatic hepatocellular carcinoma (“HCC”).

In combination with other drugs, the Tempest drug was shown to work for this particular cancer.

https://ir.tempesttx.com/news-releases/news-release-details/tempest-releases-new-data-demonstrating-superiority-tpst-1120

Obviously, the “market” liked what it learned (as though markets are personalities). At the close yesterday (10 Oct) the TPST share price was what it has been for some time, in the narrow range of $0.23. Then, this morning the news release was read and the share price ascent went up at a steep angle all day. At a good number of times during the day, the stock got a trading halt; apparently to cool things down.

At 4pm Eastern, the share price closed today at about $10.00; was varying drastically. Who knows where (or if) the share price will settle when after-hours trading finally settles on a price?

The day before, the closing TPST share price was $0.23. In 24 hours the share price increased and closed at, shall we say, $10.00. $10.00/$0.23 = 43.47826. In 24 hours, the TPST share price increased in value over 43 times; a percentage increase of 4347.83% with trading volume today of approximately 170 million shares.
<< Previous
Bullboard Posts
Next >>